Academic literature on the topic 'Assisted Reproductive Technology'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Assisted Reproductive Technology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Assisted Reproductive Technology"

1

Deep, JP. "Assisted Reproductive Technology." Journal of Chitwan Medical College 4, no. 1 (July 30, 2014): 1–10. http://dx.doi.org/10.3126/jcmc.v4i1.10840.

Full text
Abstract:
All the treatment or procedure that includes the handling of both human sperm and oocytes or embryos in vitro for the purpose of establishing a pregnancy in order to bypass some pathological obstacles in human reproduction is known as Assisted Reproductive Technology (ART). Now we must be approaching 1.5 million Assisted Reproductive Technology birth since the birth of the world’s first in vitro fertilization baby, Louise Brown, in the United Kingdom. The infertility is caused by various reason and factors from either or both partners. Infertility affects worldwide by 8-15 percent of couples in general and defined as a disease of the reproductive system by the failure to achieve a clinical pregnancy after one year or more of regular unprotected sexual intercourse. DOI: http://dx.doi.org/10.3126/jcmc.v4i1.10840 Journal of Chitwan Medical College 2014; 4(1): 1-10
APA, Harvard, Vancouver, ISO, and other styles
2

Silva, Shana Ginar da, Andréa Dâmaso Bertoldi, Mariângela Freitas da Silveira, Marlos Rodrigues Domingues, Kelly R. Evenson, and Iná Silva dos Santos. "Assisted reproductive technology." Revista de Saúde Pública 53 (January 30, 2019): 13. http://dx.doi.org/10.11606/s1518-8787.2019053000737.

Full text
Abstract:
OBJECTIVE: To assess the prevalence of successful assisted reproductive technology and to identify the associated factors. METHODS: This population-based birth cohort study was carried out with 4,333 pregnant women expected to deliver in 2015 in the urban area of Pelotas, Southern Brazil. Use of an assisted reproductive technology procedure, type of assisted reproductive technology [in vitro fertilization or intracytoplasmic sperm injection or artificial insemination], number of embryos transferred, success of embryo transfer, number of attempts, and reported reasons for seeking assisted reproductive technology were the main outcomes measured. Use of an assisted reproductive technology procedure was analyzed according to sociodemographic, nutritional, reproductive history, and behavioral characteristics. Unadjusted and adjusted analyses were performed by logistic regression. RESULTS: Among the 4,275 newborns enrolled in the Pelotas 2015 Birth Cohort Study, 18 births (0.4%) were conceived by assisted reproductive technology. Most cases of assisted reproductive technology were by in vitro fertilization (70.6%). All cycles were performed in private clinics under direct out-of-pocket payment. Even after controlling for confounders, maternal age > 35 years, nulliparity and high family monthly income were strongly associated with assisted reproductive technology. CONCLUSIONS: The use of assisted reproductive technology services was reported by only a few women in the Pelotas 2015 Birth Cohort Study. Our study highlights sociodemographic factors associated to assisted reproductive technology procedures. To better understand the patterns and barriers in overall use of assisted reproductive technology services over time, national-level trend studies in assisted reproductive technology treatments and outcomes, as well as studies exploring the characteristics of women who have sought this kind of treatment are needed in low-middle income countries.
APA, Harvard, Vancouver, ISO, and other styles
3

Yablonsky, Terri. "Assisted Reproductive Technology." Laboratory Medicine 27, no. 8 (August 1, 1996): 524–31. http://dx.doi.org/10.1093/labmed/27.8.524.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tanbo, Tom, and Thomas Åbyholm. "Assisted reproductive technology." Current Opinion in Obstetrics and Gynecology 3, no. 5 (October 1991): 649–55. http://dx.doi.org/10.1097/00001703-199110000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Watts, Robin. "Assisted reproductive technology." Collegian 4, no. 1 (January 1997): 12. http://dx.doi.org/10.1016/s1322-7696(08)60200-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Abe, Takashi, Ryoko Tomiyama, Tomoko Ichikawa, Katsuya Mine, Shigeo Akira, and Toshiyuki Takeshita. "5. Assisted Reproductive Technology A Trend of Assisted Reproductive Technology (I)." Nihon Ika Daigaku Igakkai Zasshi 5, no. 4 (2009): 184–86. http://dx.doi.org/10.1272/manms.5.184.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hogue, Carol J. Rowland. "Successful Assisted Reproductive Technology." Obstetrics & Gynecology 100, no. 5, Part 1 (November 2002): 1017–19. http://dx.doi.org/10.1097/00006250-200211000-00032.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Simón, Carlos. "Personalized assisted reproductive technology." Fertility and Sterility 100, no. 4 (October 2013): 922–23. http://dx.doi.org/10.1016/j.fertnstert.2013.08.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sacks, Preston C. "Assisted human reproductive technology." Reproductive Toxicology 6, no. 1 (January 1992): 109. http://dx.doi.org/10.1016/0890-6238(92)90028-r.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sotoya Tsuyoshi. "Assisted Reproductive Technology and Bioethics." Journal of Next-Generation Humanities and Social Sciences ll, no. 14 (March 2018): 261–79. http://dx.doi.org/10.22538/jnghss.2018..14.261.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Assisted Reproductive Technology"

1

Morgan, Jonathan J. "State Regulation of Assisted Reproductive Technology." BYU ScholarsArchive, 2010. https://scholarsarchive.byu.edu/etd/2206.

Full text
Abstract:
State regulation of assisted reproductive technology (ART) has been occurring since the inception of earlier technological advances such as artificial insemination to aid human reproduction. I provide a brief overview of the current regulation of ART in the U.S. and the literature on state regulation. Unlike previous studies of ART regulation which use content analysis or case studies of individual state laws I estimate ART regulation for the entire U.S. by using a series of random effects logistic regression models for the time period 1995-2006. To my knowledge this is the first quantitative analysis of ART regulation. I test the hypothesis that the demand for ART is an important predictor of ART legislation in the U.S. Other hypotheses derived from the ART literature were also tested in the analysis. Results indicate that demand for ART is the most influential factor in predicting ART legislation from 1995-2006. Additionally, educational attainment of a state's population and the percentage of married couple households with children in each state may have a direct effect on the demand for ART and an indirect effect on ART regulation.
APA, Harvard, Vancouver, ISO, and other styles
2

Pangestu, Mulyoto 1963. "Drying biological material for use in assisted reproductive technology." Monash University, Institute of Reproduction and Development, 2002. http://arrow.monash.edu.au/hdl/1959.1/7879.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chang, Jeani. "Relationship Between Assisted Reproductive Technology and Risk of Stillbirth." ScholarWorks, 2017. https://scholarworks.waldenu.edu/dissertations/4508.

Full text
Abstract:
Assisted reproductive technology (ART) is an infertility treatment used to assist women to become pregnant. Although the procedure is safe, there are gaps in understanding the association between treatment and adverse pregnancy outcomes (e.g., stillbirth) in the United States. The purpose of this study was to investigate the relationship between stillbirth delivery and ART. The 2 research questions addressed the association between methods of conception (ART versus non-ART) and the delivery of a stillbirth, and the association between multiple gestation pregnancy and risk of stillbirths. Retrospective cohort data from the States Monitoring ART collaborative were analyzed using Pearson's chi squared tests and log binominal regression models. Findings indicated that from 2006 to 2011, the average stillbirth rates were lower among ART-conceived pregnancies than non-ART conceived pregnancies. After controlling for confounding factors, ART-conceived pregnancies did not show increased risks of stillbirths compared to non-ART conceived pregnancies regardless of plurality. This lower risk of stillbirth was particularly significant during early pregnancies, before 28 weeks of gestation. Findings may be used to improve understanding of the use of ART treatment and its associated pregnancy outcomes. Findings may also be used to prevent stillbirths and to improve prenatal care, early stillbirth detection, and effective clinical management of fetal and maternal conditions during pregnancy.
APA, Harvard, Vancouver, ISO, and other styles
4

Batty, Lynne Patricia. "Assisted Reproductive Technology: The Aotearoa/New Zealand Policy Context: A thesis submitted in fulfilment of the requirements for the degree of Master of Arts in Sociology in the University of Canterbury." Thesis, University of Canterbury. Sociology, 2002. http://hdl.handle.net/10092/912.

Full text
Abstract:
The focus of this thesis is the current policy situation in relation to assisted reproductive technologies (ART) in Aotearoa/New Zealand. I explore how government policies (and lack of policy) have shaped access to ART. I also explore the policy initiatives of funding agencies, the National Ethics Committee on Assisted Human Reproduction (NECAHR), managers, healthcare professionals, and interest groups. My investigation into ART policy issues critically examines the various formal mechanisms and policies used to regulate and control ART in Aotearoa/New Zealand. Drawing on my analysis of policy-focused documents and material from in-depth interviews with key actors in the policy debate, I demonstrate how the ad hoc and contingent approach to ART developments, practices, funding, and access has contributed to inconsistent and inequitable access to ART services. I argue that the lack of an ART-specific policy organisation contributes to fragmented, and possibly discriminatory, policy decisions. I examine how the use of restrictive access criteria to manage the increasing demand for publicly funded ART services disadvantages certain groups wishing to use these services. By investigating the influence of rationing strategies on the allocation of resources and regulation of access, I provide some appreciation of the 'messy reality' of policy creation, interpretation, and implementation. I argue that the criteria used to limit access to public ART services obscure the use of social judgements and provider discretion. Likewise, they succeed in limiting publicly funded ART treatments to those who conform most effectively to the normative definition of family. My analysis of the ART policy discourse identifies silences and gaps in relation to specific ART practices, particularly the use of ART by Maori. I highlight the invisibility and marginalisation of Maori within the ART policy debate. After examining the broader issues concerning Maori access to health services, I explore how these may affect Maori using ART services to overcome infertility. I argue that the gathering of information about the utilisation of ART services is crucial for the accurate identification of the needs of Maori. It is also fundamental for effective monitoring of state health policy decisions and outcomes.
APA, Harvard, Vancouver, ISO, and other styles
5

McComiskey, Mark Henry. "Unrecognised healthcare consequences of children born following assisted reproductive technology." Thesis, Queen's University Belfast, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.675460.

Full text
Abstract:
The consensus is that children born following ART are delivered earlier and at a lower birthweight that those naturally conceived and have a higher likelihood of requiring admission to a neonatal intensive care unit (NICU). The longer term prospects for artificially conceived children seem comparable to the naturally conceived population for the majority of medical conditions. This study examined NICU admission registry data of children born 111/2001 to 31/12/2007. Odds ratios (OR) for NICU admission were produced. All paediatric hospital admissions in Northern Ireland 1/7/1996 through 3016/2009 were also studied. Standardised admission ratios (SAR's) for children up to 13 years old born following ART were calculated. Unadjusted OR for NICU admission was 0.92 (95% CI 0.71, 1.18) for singleton~ and 0.83 (95% CI 0.69, 0.99) for twins. Adjustment for hospital, gestation and year showed OR for NICU admission to be 0.68 (95% CI 0.49, 0.93) for singletons and 0.76 (95% CI 0.60, 0.97) for twins. SAR for all- and first hospital admissions in ART children were 80 (95% CI 76, 84) and 74 (95% CI 68, 80) respectively. Children born fOllowing IVF had increased all-hospital SAR compared to those born following ICSI (SAR 85, 95% CI 80, 90 vs. SAR 71,95% C164, 77; p=0.001). Those born following fresh embryo had increased all-hospital SAR compared to those born fallowing frozen embryo transfer. All-admission analysis showed Significant increases in SAR with diagnoses of cerebral palsy and inguinal hernia. Non-significant trend for increased SAR for all-hospital admission and first-hospital admission was found for some diagnoses. This study adds some reassurance to the neonatal and long-term child health of those born following ART. IVF children and those born following fresh embryo transfer may not be as healthy throughout childhood as their ICSI and frozen embryo transfer peers. Published concerns regarding neurological conditions and congenital abnormalities in children conceived using ART are supported by this study.
APA, Harvard, Vancouver, ISO, and other styles
6

Ellender, Stacey. "Assisted reproduction defining and evaluating the multiple outcomes of technologically advanced interventions /." online access from Digital Dissertation Consortium, 2005. http://libweb.cityu.edu.hk/cgi-bin/er/db/ddcdiss.pl?3193097.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wilson, Poe Emma. "Vitrification of day 5/6 human morulas/blastocysts: A 10 year retrospective study in a private assisted reproductive techniques [ART] clinic." Thesis, Stellenbosch : Stellenbosch University, 2015. http://hdl.handle.net/10019.1/96876.

Full text
Abstract:
Thesis (MMed)--Stellenbosch University, 2015.
ENGLISH ABSTRACT: This study was designed to retrospectively evaluate the established embryo vitrification/warming programme currently implemented at Drs Aevitas Institute for Reproductive Medicine and to look at factors that might play a role in optimizing the pregnancy outcomes thereof. Vitrification is the achievement of a “state of suspended animation” wherein molecular translational motions are arrested without structural reorganization of the liquid. In embryo vitrification it involves placement of the embryo in a very small volume of vitrification medium that must be cooled at extremely high cooling rates. The vitrification medium contains cryoprotectants to prevent any cryoinjury from occurring to the embryo. This process was initially proposed to effectively manage supernumerary embryos, but it has also provided a viable method of reducing costs for additional embryo transfers as well as the reduction of the incidence of multiple births. Patients who are at risk of ovarian hyper stimulation syndrome (OHSS) can also have all of their embryos vitrified in advance to reduce the likelihood of adverse clinical symptoms if a pregnancy is established. Throughout the period in which vitrification has been in practice, there have been advances in technology as well as continual research being conducted to establish whether newly suggested techniques do, in fact, optimize the outcomes of vitrification. Focus has subsequently been applied to the carrier device used for vitrification, the day on which the embryos are vitrified and stored, as well as the number of embryos transferred in each respective cycle, all to ensure the most favourable outcome. This retrospective study confirmed the use of the Cryotop® as the most viable carrier device for successful survival and pregnancy outcomes. Transfer of day 5 vitrified embryos resulted in significantly higher pregnancy rates compared to day 6 vitrified embryos. Results also indicated that the number of embryos transferred does indeed have a significant effect on the pregnancy outcome and consequently we can possibly argue against the implementation of single embryo transfer in the vitrification programme. Investigation into the effect of female age, specifically oocyte age, on each of these categories indicated that reduced age can be associated with optimal outcomes; however this could not be proven statistically in this cohort of patients. To further look at optimization of the vitrification/warming programme, a Literature Survey was conducted to ascertain the results after Assisted Hatching in frozen/warmed human embryos. Assisted Hatching has been proposed as a solution to Zona Pellucida hardening, which has been found to occur during vitrification. The need for further studies and a meta-analysis of the literature is confidently proposed, as well as a Prospective Study to evaluate the effect of Laser Assisted Hatching in the human blastocyst vitrification/warming programme at Drs Aevitas Institute for Reproductive Medicine.
AFRIKAANSE OPSOMMING: Hierdie studie is ontwerp om die gevestigde embrio vitrifikasie/ontdooi program by Drs Aevitas Instituut vir Reproduktiewe Medisyne, retrospektief te evalueer en die faktore te optimaliseer wat swangerskap uitkomste kan beïnvloed. Vitrifikasie is die proses waardeur die molekulere aktiwiteit binne die embrio in ‘n staat van arres gehou word sonder om die strukture binne die sitplasma te versteur. Dit behels die plasing van ʼn embrio in 'n klein hoeveelheid vitrifikasie medium wat teen 'n hoë tempo afgekoel word. Die vitrifikasie medium bevat kriobeskermmiddels wat die embrio tydens die vitrifikasie proses teen moontlike skade beskerm. Hierdie proses is aanvanklik voorgestel om oortollige embrio’s doeltreffend te bestuur. Dit bied ʼn koste effektiewe metode vir embrio terugplasing, en verlaag die insidensie van veelvoudige swangerskap. Vitrifikasie bied pasiënte met ʼn hoë risiko vir ovariale hiperstimulasiesindroom (OHSS) ‘n alternatief om nadelige kliniese simptome te vermy indien ʼn swangerskap bereik word. Tegnologiese vordering en voortdurende navorsing ondersoek voortdurend nuwe tegnieke vitrifikasie uitkomste te optimaliseer. Fokus word geplaas op die draertoestel wat gebruik word vir vitrifikasie, die dag waarop die embrio's gevitrifiseer en gestoor word, sowel as die aantal embrio’s wat met elke vitrifikasie siklus teruggeplaas word. Hierdie retrospektiewe studie het bevestig dat die gebruik van die Cryotop® die mees suksesvolle toestel vir oorlewing en swangerskap uitkomste is. Die terugplasing van dag 5 gevitrifiseerde embrios het beduidende hoër swangerskapsyfers as dag 6 embrios tot gevolg gehad. Die resultate het ook aangedui dat die aantal embrio's wat teruggeplaas word 'n beduidende uitwerking op die swangerskapsyfer het. Daar kan dus moontlik teen die implementering van 'n enkel embrio-terugplasing neiging in die vitrifikasie program geargumenteer word. Resultate het ook getoon dat optimale uitkomste verwant is aan ʼn laer oösiet ouderdom, alhoewel dit nie in die groep pasiente statisties bewys kon word nie. 'n Literatuurstudie oor AH (Assisted Hatching) op gevitrifiseerde/ontdooide menslike embrio’s is uitgevoer om die vitrifikasie/ontdooi program verder te optimaliseer. AH bied ‘n oplossing vir Zona pellucida verharding, wat tydens vitrifikasie plaasvind. Verdere studies, 'n meta-analise van die literatuur, sowel as 'n prospektiewe studie om die effek van laser AH in gevitrifiseerde/ontdooide menslike blastosiste by Drs Aevitas Instituut vir reproduktiewe medisyne te evalueer, word voorgestel.
APA, Harvard, Vancouver, ISO, and other styles
8

Hoogendijk, Christiaan F. (Christiaan Frederik). "Sperm DNA fragmentation : implications in assisted reproductive technologies." Thesis, Stellenbosch : Stellenbosch University, 2007. http://hdl.handle.net/10019.1/21626.

Full text
Abstract:
Dissertation (PhD)--University of Stellenbosch, 2007.
ENGLISH ABSTRACT: Male fertility has for many years been defined in vitro as the ability of sperm to fertilize oocytes and to obtain early cleavage-stage embryos. Spermatozoa comprise of an extraordinary high percentage of polyunsaturated fatty acids in their plasma membrane. Due to an extremely low content of cytoplasm, sperm cells have a particularly low potential to scavenge reactive oxygen species (ROS), and are therefore highly sensitive to oxidative processes, which lead to sperm nucleus DNA damage/fragmentation. Normally, DNA fragmentation occurs in every ejaculate and can be induced by an excessive ROS production of active leukocytes or the spermatozoa themselves. Under distressed conditions, DNA fragmentation may also occur in the testis as a result of oxidative processes in the apoptotic cascade. These DNA fragmentations can be regarded as late signs of programmed cell death (apoptosis). Clinically, DNA fragmentation in spermatozoa results in significantly decreased implantation and pregnancy rates especially in patients with oligo- and/or teratozoospermia. The p-pattern normal sperm morphology has been shown to give poorer fertilization rates in vitro than the g- and n-patterns. In this study there is reported on the significant correlation found between the p-pattern normal sperm morphology and sperm DNA fragmentation as measured with the terminal deoxynucleotidyl transferase-mediated dUDP-biotin end labeling (TUNEL) assay. This finding further explains the lower fertility potential of patients presenting with p-pattern normal sperm morphology. In addition, this study explores the intricate relations between ROS in the semen, DNA fragmentation of the spermatozoa, as measured with the TUNEL assay and the sperm chromatin structure assay (SCSA ), spermatozoa apoptotic status and sperm parameters as measured with a standard semen analysis. Positive correlations were found between ROS and the apoptotic status of the sperm, as well as between sperm with non-fragmented DNA and sperm concentration and percentage motility. The results emphasize the importance of sperm selection especially when the treatment of choice is intracytoplasmic sperm injection (ICSI). An early sign of programmed cell death, also known as apoptosis, is the externalization of phosphatidylserine (PS) from the inner membrane leaflet to the outer leaflet. PS shows a high affinity to Annexin V. Apoptotic spermatozoa are able to fertilize oocytes, but embryo senescence may occur at the time when the paternal genes are activated. In this study there is reported on a novel method whereby spermatozoa can be separated on the basis of their apoptotic status through flow cytometry. Results showed that the normal sperm morphology, according to strict criteria, of the resultant nonapoptotic sperm fraction is significantly higher than that of the apoptotic counterpart. With refinement of this technique, it will be possible in future to use these separated non-apoptotic sperm cells during ICSI for fertilization. From the above it is apparent that the spermatozoon has to play a vital role in the development of the embryo from fertilization to implantation and pregnancy. It is, however, important to note that besides the gametes, there are other critical factors which contribute to a successful in vitro fertilization (IVF) cycle, among these are the in vitro culture conditions. In this regard, this study compared two sequential embryo culture systems. It was found that the more complex medium resulted in better day three embryo quality and a better blastocyst formation rate and pregnancy rate. These findings highlight the importance of a holistic perspective towards the complexity of the factors involved in affecting embryo quality and pregnancy outcome.
AFRIKAANSE OPSOMMING: Manlike fertiliteit is vir baie jare gedefinieer as die in vitro vermoë van ‘n spermsel om ‘n eiersel te bevrug om sodoende embrios te verkry. Die spermsel se plasmamembraan bestaan uit ‘n hoë persentasie poli-onversadigde vetsure. As gevolg van die klein hoeveelhede sitoplasma van die spermsel het dit ‘n beperkte weerstand teen reaktiewe suurstof spesies (ROS) en is gevolglik baie sensitief vir oksidasie. Oksidasie lei tot DNS skade/fragmentasie. DNS fragmentasie kom in spermselle van alle ejakulate voor en is gewoonlik die gevolg van ROS produksie deur die leukosiete in die semen of vanaf die spermselle self. Onder sekere omstandighede kan DNS fragmentasie ook voorkom in die testis waar dit deel vorm van apoptose. Hierdie tipe DNS skade word gesien as laat tekens van geprogrammeerde seldood (apoptose). In oligo- en/of teratozoospermiese mans lei DNS fragmentasie tot verlaagde implantasie- en swangerskapssyfers. Die p-patroon normale sperm morfologie groep gee laer in vitro bevrugting en swangerskapsyfers as die g- en n-patrone. In hierdie studie doen ons verslag oor die statisties betekenisvolle korrelasie wat gevind is tussen die p-patroon normale sperm morfologie en DNS fragmentasie soos gemeet met die ‘terminal deoxynucleotidyl transferase-mediated dUDP-biotin end labeling’ of te wel TUNEL toets. Hierdie bevinding is ‘n verdere verklaring vir die laer fertiliteits potensiaal van pasiënte wat voordoen met p-patroon sperm morfologie. ‘n Verdere doel van die studie was om die moontlike verband tussen ROS in die semen, spermatozoa DNS fragmentasie, apoptotiese status van die sperms en die motiliteits parameters van die spermatozoa te bepaal. ‘n Positiewe korrelasie is gevind tussen ROS en sperm apoptotiese status. Sperms met ongeframenteerde DNS is ook positief gekorreleer met sperm konsentrasie en motiliteit. Die resultate beklemtoon die belangrikheid van spermseleksie veral in pasiënte waar die keuse van behandeling intrasitoplasmiese sperm inspuiting (ICSI) is. ‘n Vroeë teken van apoptose is die eksternalisering van ‘phosphatidylserine’ (PS) vanaf die interne oppervlakte van die plasmamembraan na die eksterne oppervlak. PS het ‘n hoë affiniteit vir Annexin V. Apoptotiese sperms het die vermoë om ‘n oösiet te bevrug, maar kan lei tot die staking van embrio deling wanneer die vaderlike gene ‘n rol begin speel in embrio ontwikkeling. In hierdie studie het ons ‘n nuwe metode ontwikkel waarvolgens die spermatozoa in die ejakulaat op grond van hul apoptotiese status geskei kan word in apoptotiese en nie-apoptotiese fraksies. Die normale sperm morfologie van die nie-apoptotiese fraksie is betekenisvol beter as dié van die apoptotiese fraksie. Verdere verfyning van die tegniek kan daartoe lei dat dit in die toekoms toegepas kan word om vir nie-apoptotiese sperms te selekteer veral voor die uitvoering van ICSI. Uit die bogenoemde is dit duidelik dat die spermsel ‘n baie belangrike rol in die ontwikkeling van ‘n embrio, vanaf bevrugting tot implantasie en swangerskap, speel. Dit is egter ook belangrik om in gedagte te hou dat daar ander bydraende faktore tot ‘n suksesvolle in vitro swangerskap is, soos laboratorium toestande en embrio kultuursisteem. Om hierdie rede is daar ook twee kultuurmedia in hierdie studie vergelyk. Daar is bevind dat die meer komplekse medium beter kwaliteit embrios op dag drie lewer, asook meer blastosiste en ‘n hoër swangerskapsyfer. Dit is dus duidelik dat dit uiters belangrik is om ‘n holistiese perspektief te hê op die komplekse faktore wat ‘n invloed mag hê op bevrugting, embrio kwaliteit asook die swangerskapsyfer.
APA, Harvard, Vancouver, ISO, and other styles
9

Smith, Heather K. "The impact of framing on policy passage: the case of assisted reproductive technology." Thesis, Georgia Institute of Technology, 2011. http://hdl.handle.net/1853/42774.

Full text
Abstract:
In the last 30 years, in vitro fertilization (IVF) has created a significant amount of controversy around the world. Within the U.S., policy movement has been limited, occurring primarily at the state level, which has created a fragmented system of rules to manage the technology. However, there appear to be indications that how the issue is presented, and which actors are chosen to be represented in legislation, may impact the passage of policy, thereby also providing a reason for why little policy movement has occurred. In this study, pieces of federal, California and Georgia legislation were examined for the occurrence of differing frames, as identified by the actors presented, in order to determine whether different frames occurred in passed legislation than those found in failed legislation. It was determined that, while actors did not differ significantly between passed and failed legislation, there were some slight differences between actors used at the federal level, as well between the different state levels. Even further, the presentation of actors and their interests did appear to differ slightly between passed and failed legislation.
APA, Harvard, Vancouver, ISO, and other styles
10

Goldsmith, Shona. "Population studies of assisted reproductive technology and congenital anomalies in cerebral palsy." Thesis, The University of Sydney, 2019. https://hdl.handle.net/2123/21909.

Full text
Abstract:
BACKGROUND: Risk factors for cerebral palsy (CP) have been identified across the conception, pregnancy, perinatal and postneonatal periods, including Assisted Reproductive Technology (ART) and congenital anomalies. ART likely increases risk of CP through mediating factors including multiple and preterm birth, but this requires further investigation in Australia. While congenital anomalies are an identified risk factor for CP, their reported prevalence varies widely. This thesis describes the epidemiology of CP with respect to these two independent factors. METHODS: A series of population-based studies were conducted. The influence of ART on prevalence of CP and clinical outcomes in Western Australia was explored in a population-based data-linkage study. Population-based research describing congenital anomalies in CP was synthesised in a systematic literature review. The most common congenital anomaly in CP from the review, congenital microcephaly, was investigated in a Western Australian population case-control study. Finally, population data-linkages were conducted in Australia and Europe to examine major congenital anomalies and outcomes in children with pre/perinatally acquired CP and postneonatally acquired CP (PNN-CP). RESULTS: ART was associated with a two-fold increased risk of CP. While multiple and preterm births were common after ART, additional risk of CP existed for very preterm ART singletons. The systematic review identified congenital anomalies in 12–32% of children with pre/perinatal CP and 20% of PNN-CP. Children with CP had a three-fold risk of congenital microcephaly in the case-control study. In Australia and Europe, congenital anomalies were identified in approximately one in four children with CP. Isolated cerebral anomalies were most common in children with pre/perinatally acquired CP, and isolated cardiac anomalies in PNN-CP. Congenital anomalies were associated with more severe outcomes for children with pre/perinatally acquired CP, but not PNN-CP. CONCLUSION: ART and congenital anomalies are important factors in the epidemiology of CP, and opportunities for prevention may lie in these pathways to CP. Research is planned to: a) evaluate temporal trends in ART and CP in Australia and b) further elucidate pathways and risk of CP for children with specific anomalies.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Assisted Reproductive Technology"

1

P, Marrs Richard, ed. Assisted reproductive technologies. Boston: Blackwell Scientific Publications, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gardner, David K., Botros R. M. B. Rizk, and Tommaso Falcone, eds. Human Assisted Reproductive Technology. Cambridge: Cambridge University Press, 2009. http://dx.doi.org/10.1017/cbo9780511734755.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hafez, E. S. E. 1922-, ed. Assisted human reproductive technology. New York: Hemisphere, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pregnancy after assisted reproductive technology. Cambridge: Cambridge University Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jauniaux, Eric, and Botros Rizk, eds. Pregnancy After Assisted Reproductive Technology. Cambridge: Cambridge University Press, 2012. http://dx.doi.org/10.1017/cbo9780511902604.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Stevenson, Eleanor L., and Patricia E. Hershberger, eds. Fertility and Assisted Reproductive Technology (ART). New York, NY: Springer Publishing Company, 2016. http://dx.doi.org/10.1891/9780826172549.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Commission, Victorian Law Reform. Assisted reproductive technology & adoption: Final report. Melbourne: Victorian Law Reform Commission, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

De, Jonge Christopher J., and Barratt C. L. R, eds. Assisted reproductive technology: Accomplishments and new horizons. Cambridge, UK: Cambridge University Press, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

K, Gardner David, ed. Textbook of assisted reproductive techniques: Laboratory and clinical perspectives. 2nd ed. London: Taylor & Francis, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

K, Gardner David, ed. Textbook of assisted reproductive technologies: Laboratory and clinical perspectives. 3rd ed. London: Informa Healthcare, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Assisted Reproductive Technology"

1

Abrams, David B., J. Rick Turner, Linda C. Baumann, Alyssa Karel, Susan E. Collins, Katie Witkiewitz, Terry Fulmer, et al. "Assisted Reproductive Technology." In Encyclopedia of Behavioral Medicine, 139. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_100120.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Vukadinovich, David M., and Susan L. Krinsky. "Assisted Reproductive Technology." In International Library of Ethics, Law, and the New Medicine, 89–111. Dordrecht: Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-015-9674-9_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Fauser, Bart C. J. M., and Didi D. M. Braat. "Assisted reproductive technology." In Textbook of Obstetrics and Gynaecology, 263–82. Houten: Bohn Stafleu van Loghum, 2019. http://dx.doi.org/10.1007/978-90-368-2131-5_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Datta, Sanjay, Bhavani Shankar Kodali, and Scott Segal. "Assisted Reproductive Technology." In Obstetric Anesthesia Handbook, 387–98. New York, NY: Springer New York, 2009. http://dx.doi.org/10.1007/978-0-387-88602-2_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Matteo, Maria. "Assisted Reproductive Technology." In Practical Clinical Andrology, 237–50. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-11701-5_18.

Full text
Abstract:
AbstractThe human species is biologically distinguished by low fertility. In fact, with each menstrual cycle, a couple at the peak of their reproductive capacity has only about a 30% chance of conceiving. The WHO states infertility as “a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected intercourse.”Assisted reproductive technology (ART) consists of all treatments or procedures that include the in vitro handling of both human oocytes and sperm or of embryos, for the purpose of establishing a pregnancy.The techniques are usually divided into three broad categories: First level techniques: Intrauterine and Intracervical Insemination (IUI/ICI), the simpler and less invasive ones, such as intrauterine insemination (IUI) with or without Intracervical Insemination (ICI) ovarian stimulation. Second level techniques: the more complex and more invasive ones that can be performed under local anesthesia or deep sedation, which differ from the basic techniques as they involve manipulation of female and male gametes and because they require in vitro fertilization. Among these techniques the IVF (In Vitro Fertilization and Embryo Transfer), ICSI (Intracytoplasmic Sperm Injection), and the possible cryopreservation of male and female gametes and embryos. Third level techniques procedures that require general anesthesia with intubation, including: laparoscopic egg retrieval, intra-tubal transfer of male and female gametes (GIFT), zygotes (ZIFT) and /or embryos (TET) laparoscopically; microsurgical sampling of gametes from the testicle: Testicular Sperm Extraction (TESE), Microsurgical Testicular Sperm Extraction (microTESE), Testicular Sperm Aspiration (TESA); microsurgical sampling of gametes from the epididymides: Percutaneous Epididymal Sperm Aspiration (PESA) and Microsurgical Epididymal Sperm Aspiration (MESA). In all assisted reproduction techniques, the seminal fluid receives a treatment able to induce capacitation “in vitro” so that the activated spermatozoa, at the threshold of the acrosomal reaction, can interact with the mature oocytes. Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD) are highly specialized procedures which involve removing three to four cells from a 5–6 day old blastocyst and testing them for chromosomal abnormalities prior to transferring the embryo into a woman’s uterus. According to data reported from the European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), the clinical pregnancy rates (PR) per aspiration and per transfer are 28.0% and 34.8%, respectively. After ICSI, the corresponding rates are 24% and 33.5%. ART can alleviate the burden of infertility on individuals and families, but it can also present challenges to public health as evidenced by the high rates of multiple delivery, preterm delivery, and low birth-weight delivery experienced with ART.
APA, Harvard, Vancouver, ISO, and other styles
6

ten Have, Henk, and Maria do Céu Patrão Neves. "Assisted Reproductive Technology." In Dictionary of Global Bioethics, 137. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54161-3_65.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pereira, Nigel, and Zev Rosenwaks. "Assisted Reproductive Technology." In Problem-Focused Reproductive Endocrinology and Infertility, 213–21. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-19443-6_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Peterson, C. Matthew, Ahmad O. Hammoud, Erika Lindley, Douglas T. Carrell, and Karen Wilson. "Assisted Reproductive Technology Practice Management." In Reproductive Endocrinology and Infertility, 7–37. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-1436-1_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Banks, Nicole, and James H. Segars. "Epigenetics and Assisted Reproductive Technology." In Epigenetic Epidemiology, 117–36. Dordrecht: Springer Netherlands, 2011. http://dx.doi.org/10.1007/978-94-007-2495-2_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Schenker, Joseph G. "Assisted Reproductive Technology: Artificial Insemination." In Encyclopedia of Global Bioethics, 185–91. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-09483-0_29.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Assisted Reproductive Technology"

1

de Haan, J., CJM de Groot, A. Bouwman, MB Crijns, ACJ van Akkooi, F. Amant, and CAR Lok. "P99 Recurrent melanoma after pregnancy and assisted reproductive technology." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.159.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bajkovec, Lucija, Ines Begović, Ana-Marija Đaković, Milan Milošević, Urelija Rodin, and Aida Mujkić. "475 Assisted reproductive technology techniques and risk for neurodevelopmental disorders." In 10th Europaediatrics Congress, Zagreb, Croatia, 7–9 October 2021. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021. http://dx.doi.org/10.1136/archdischild-2021-europaediatrics.475.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Koseki, Susumu, Kazuhiro Kawamura, Futoshi Inoue, Koji Ikuta, and Masashi Ikeuchi. "Magnetically Controlled Microrobot for Embryo Transfer in Assisted Reproductive Technology." In 2019 20th International Conference on Solid-State Sensors, Actuators and Microsystems & Eurosensors XXXIII (TRANSDUCERS & EUROSENSORS XXXIII). IEEE, 2019. http://dx.doi.org/10.1109/transducers.2019.8808545.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lepore, Mario, and Antonio Petruzziello. "A Situation-Aware DSS to Support Assisted Reproductive Technology Outcome Prediction." In 2021 IEEE Conference on Cognitive and Computational Aspects of Situation Management (CogSIMA). IEEE, 2021. http://dx.doi.org/10.1109/cogsima51574.2021.9475933.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

HongQing, Liao, and Ouyang Xinping. "The effect of sperm morphology on the outcome of Assisted Reproductive Technology." In 2014 2nd International Conference on Advances in Social Science, Humanities, and Management. Paris, France: Atlantis Press, 2014. http://dx.doi.org/10.2991/asshm-14.2014.77.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Alekseeva, Liliya L., Ayuna Ts Budatsyrenova, and Marina R. Mangataeva. "Gestation course after the methods of assisted reproductive technology in the Buryat Republic." In Eurasian paradigm of Russia: values, ideas and experience. Buryat State University Publishing Department, 2015. http://dx.doi.org/10.18101/978-5-9793-0814-2-198-200.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Paolanti, Marina, Marco Mameli, Emanuele Frontoni, Giorgia Gioacchini, Elisabetta Giorgini, Valentina Notarstefano, Carlotta Zaca, Oliana Carnevali, and Andrea Borini. "Automatic Classification of Human Granulosa Cells in Assisted Reproductive Technology using vibrational spectroscopy imaging." In 2020 25th International Conference on Pattern Recognition (ICPR). IEEE, 2021. http://dx.doi.org/10.1109/icpr48806.2021.9412544.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sasaki, Hayato, Masaya Nakata, Mizuki Yamamoto, Teppei Takeshima, Yasushi Yumura, and Tomoki Hamagami. "Investigation about Control of False Positive Rate for Automatic Sperm Detection in Assisted Reproductive Technology." In 2018 IEEE International Conference on Systems, Man, and Cybernetics (SMC). IEEE, 2018. http://dx.doi.org/10.1109/smc.2018.00339.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yang, Rui. "Research on Quantitative Methylation Action of PEG1 in Assisted Reproductive Technologies by Network Video Consultation Platform." In 2015 7th International Conference on Information Technology in Medicine and Education (ITME). IEEE, 2015. http://dx.doi.org/10.1109/itme.2015.139.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Puumala, Susan E., Heather H. Nelson, Julie A. Ross, Ruby H. N. Nguyen, Mark A. Damario, and Logan G. Spector. "Abstract 1897: DNA methylation levels in specific imprinting control regions in children conceived with and without assisted reproductive technology (ART)." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-1897.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Assisted Reproductive Technology"

1

Leroux, Marie-Louise, Pierre Pestieau, and Gregory Ponthiere. The optimal design of assisted reproductive technologies policies. CIRANO, June 2022. http://dx.doi.org/10.54932/ezmm9028.

Full text
Abstract:
This paper studies the optimal design of assisted reproductive technologies (ART) policies in an economy where individuals differ in their reproductive capacity (or fecundity) and in their wage. We find that the optimal ART policy varies with the postulated social welfare criterion. Utilitarianism redistributes only between individuals with unequal fecundity and wages but not between parents and childless individuals. To the opposite, ex post egalitarianism (which gives absolute priority to the worst-off in realized terms) redistributes from individuals with children toward those without children, and from individuals with high fecundity toward those with low fecundity, so as to compensate for both the monetary cost of ART and for the disutility from involuntary childlessness resulting from unsuccessful ART investments. Under asymmetric information and in order to solve for the incentive problem, utilitarianism recommends also to either tax or subsidize ART investments of low-fecundity-low productivity individuals depending on the degree of complementarity between fecundity and ART in the fertility technology. On the opposite, ex post egalitarianism always recommends marginal taxation.
APA, Harvard, Vancouver, ISO, and other styles
2

Wang, Fangfang, Tao Yu, Xiaolu Chen, Rong Luo, and Dezhi Mu. Assisted reproductive technology and the risk of cerebral palsy in the offspring: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2021. http://dx.doi.org/10.37766/inplasy2021.3.0060.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography